FEBS Letters · 1999 · 16 citations · 23 references
Life SciencesBiochemistryMolecular BiologyEnzymologyMolecular VirologyVirologyEnzyme FunctionEnzyme InhibitionProtein ChemistryProtein StructureProteolytic EnzymesViral HepatitisC1 InhibitorProtease InhibitionProtease InhibitorsProtease TreatmentReactivityRegulation By Serine Protease InhibitorsViral Protease InhibitionViral Proteases
Both NS3 protein (1007-1657) and its protease moiety (NS3p, 1027-1207) were able to interact in vitro with C1 Inhibitor (C1Inh) to give a 95-kDa Mr C1Inh cleavage product similar to that obtained upon proteolysis by complement protease C1s. High-Mr reaction products were also detected after incubation of C1Inh with NS3 but not with NS3p; they correspond to ester-bonded complexes from their hydroxylamine lability. Similar reactivity of NS3 was observed upon incubation with alpha2-antiplasmin. Serpin cleavage was prevented by treatment of NS3 with synthetic serine protease inhibitors. This interaction between viral NS3 and host serpins suggests that NS3 is likely to be controlled by infected cell protease inhibitors.
23
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
Ulrich K. Laemmli · Nature · 1970 · 251.6K citations
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Qui‐Lim Choo, George Kuo, Amy J. Weiner et al. · Science · 1989 · 6.9K citations
Target Protease Specificity of the Viral Serpin CrmA
Qiao Zhou, Scott J. Snipas, Kim Orth et al. · Journal of Biological Chemistry · 1997 · 515 citations · Full text